Credit Corp Group (ASX: CCP) — Investment Research Report

3-Year / 5-Year Price Scenarios

Base EPS: $1.55 — FY26 EPS (AUD)

0. Information Richness & AI Limitations

Grade A. Mid-cap ASX financial, dense coverage. Core question: is CCP an 'over-sold, well-managed, recovering, cheap financial with US/UK growth options,' or a 'cyclical, capital-intensive, regulation-sensitive value trap'? Verified data conflict: some sources showed A$10.07 / A$685M market cap — verified as stale/wrong. Correct current values: price A$13.76, market cap ~A$937M, 68.07M shares (stockanalysis). Down 26% from the 52-week high and ~63% from the 2021 peak (A$37).

1. Data & Cross-Validation

Price A$13.76; 68.07M shares; market cap ~A$937M (prior-close A$913.46M verified 0.00%; +2.53% intraday); PE(TTM) 9.8x, forward 8.5x (cheap); EPS TTM A$1.37; dividend A$0.68 (5.1%); 52-week A$9.50–18.48; analyst target A$18.62.

5-year trend (AUD, FY ends June): revenue A$336→447M; net income A$88→101→91→51 (FY24 trough)→94 (FY25 recovery, +16%); EPS A$1.30→1.49→1.32→0.74→1.37. FY24 was a trough (US collections stumble + PDL writedown), FY25 recovered strongly; FY26 guided NPAT A$100-110M (+12%). FCF negative in FY22-24 (PDL purchases are core investment cash outflow — normal for a debt buyer, not distress), positive A$51M FY25. Segments: PDL (purchased-debt-ledger) buying ANZ (leader) + US (growth, record pipeline, 70% of FY26 secured); consumer lending (record A$425M FY26, +15%); UK expansion (FY26 new). Ledger investment guidance FY26 A$295-330M (+31%).

2. Business Essence — Duan Yongping

One line: Australasia's largest 'bad-debt hunter' — buying defaulted consumer debt from banks/telcos at cents on the dollar and collecting more than it paid (via 20+ years of pricing data + collection efficiency), plus lending to sub-prime consumers. A discipline-driven, cyclical, capital-intensive, regulation-scrutinized specialist financial — now cheap after a stumble.

Strengths: ANZ leader + data/pricing moat (20+ years of collections data + pricing models + scale — knows what a debt ledger is worth); management discipline is the real alpha (CEO Beregi, ~18 years, is famed for capital discipline — buying little / sitting out when PDL prices spike, then scooping up cheaply after rivals blow up — CCP's cross-cycle edge); growth options (US record pipeline, UK new, consumer lending record volume); cheap + income + recovery (8.5x forward, 5.1% yield, +16% earnings recovery, down 63% from peak); counter-cyclical (downturns increase debt supply + lower purchase prices — seeding future returns).

But (why cheap): PDL pricing competition (in good times rivals overpay for debt, compressing industry returns — the biggest recurring risk); US execution risk (FY24's stumble is the lesson — new-market execution is double-edged); consumer-lending credit + regulation risk (sub-prime lending; small-amount credit/collections are politically sensitive — responsible lending, collection conduct); capital-intensive + cyclical (must keep buying PDLs, FY26 guide A$295-330M).

Duan's verdict: a 'discipline-driven, cyclical, regulation-sensitive specialist financial, but excellent management and cheap.' Duan: buying bad debt and sub-prime lending isn't my favorite business — cyclical, capital-heavy, regulators watching. But Beregi is a rare management: disciplined enough to sit out when rivals scramble for debt, then strike after they blow up — that anti-human discipline is this business's only reliable moat. With earnings recovering, the stock down 63%, 8.5x, 5% yield — good management + cheap price + recovery makes a solid value position; but it's a cyclical, not a steady compounder.

3. Moat — Buffett

Brand/pricing ★★☆☆☆ (a buyer to upstream banks, no 'pricing power' over debtors; the core skill is 'pricing a bad-debt ledger correctly'); switching costs ★★☆☆☆ (sticky procurement relationships with banks/telcos, but PDLs are mostly tendered); network effects ☆; scale ★★★★☆ (core moat — largest ANZ scale + 20+ years of collections data + low-cost collections platform + funding advantage → leading unit cost + pricing precision); data/pricing + discipline ★★★★☆ (20+ years of default-debt data + pricing models + management's capital discipline — a soft edge that can't be built quickly).

Trend: scale + data moat stable; but PDL pricing competition cyclically erodes industry returns — the moat is more 'making fewer mistakes than rivals' than 'structural monopoly.' Buffett question: scale/data/discipline moat likely persists 10 years out — debt collection always exists, and CCP's data + discipline are long-accumulated. Threats: (1) prolonged industry pricing irrationality (rivals keep overpaying, crushing returns); (2) regulatory tightening (collection conduct, small-amount lending rules) raising costs or restricting business; (3) US/UK execution failure burning capital + reputation; (4) key-person risk (if Beregi's discipline culture breaks in succession). The moat is 'data + scale + discipline,' with discipline heavily dependent on management — both a strength and a key-person risk.

4. Reverse Thinking & Risks — Munger

Analogies: cautionary — the debt-buying industry is markedly cyclical: in good times rivals overpay for debt then blow up on writedowns; US peers (Encore/PRA) have cycled similarly; CCP itself took a FY24 US writedown and halved. Positive — CCP has repeatedly expanded counter-cyclically at industry troughs (rivals exit, PDLs cheap) and reaped big gains later — Beregi's discipline makes it a 'greedy when others are fearful' winner. That cross-cycle discipline is the key to its long-term outperformance. Munger (capital cycle): debt-buying is a classic capital-cycle game — high returns attract entrants → prices up → returns crushed → blow-ups → exits → returns recover. 'In such a cyclical industry, the only reliable moat is capital discipline — restraint while others are greedy. CCP happens to have exactly that management, which deserves a premium. But it remains a cyclical, and regulation is a sword overhead.' Munger question / why suppressed now: debt-buying/sub-prime is cyclical, capital-intensive, regulation-sensitive; it just took a US writedown in FY24, and PDL pricing competition can compress returns anytime. Skeptics: 'I respect the management, I grant it's cheap, but returns are set by the industry pricing cycle and regulation, not fully in its control; 8.5x isn't dear, but a cyclical financial + regulatory risk warrants the discount.'

5. Management — Duan Yongping + Buffett (the standout positive)

Thomas Beregi (CEO ~18 years, since ~2008), with long-time CFO Michael Eadie — a rare long tenure + discipline culture spanning multiple cycles. Across cycles, deliberately buys little / sits out when PDL prices spike, then buys cheaply after rivals blow up — the anti-human capital discipline that is CCP's core cross-cycle alpha. Post-2015 expanded into US debt-buying + consumer lending (visionary growth, though FY24's US stumble/writedown shows execution has bumps); FY26 UK expansion + record US pipeline + record lending volume. Steady dividend, transparent disclosure, no governance scandal.

Assessment: management is CCP's biggest moat — Beregi's ~18-year tenure + capital discipline (not chasing overpriced debt) + counter-cyclical expansion is the scarcest, most reliable alpha in this cyclical business — the 'right person' Buffett/Duan prize most. But FY24's US stumble is a reminder — even great management makes mistakes and writedowns when expanding into new markets; discipline ≠ never wrong. No integrity red light.

Duan question: if Beregi retires, does it stay competitive? This is CCP's biggest key-person risk. Scale/data moat persists, but 'capital discipline' depends heavily on Beregi and the culture he built — if a successor chases overpriced debt in a boom (the industry's most common mistake), the core edge erodes. CFO Eadie is a long-time partner and the culture has depth, but Beregi's succession is a key variable to track closely.

6. Industry & Civilizational Trend — Li Lu

Not a paradigm shift. Debt-buying/collections/consumer lending is a mature, cyclical financial niche. Demand is durable + counter-cyclical (downturns create more defaulted debt to process); consumer credit grows modestly with the economy but is regulation-constrained. Value-chain position: the 'distressed-asset processing layer' of the consumer-credit ecosystem — banks/telcos sell uncollectable debt to CCP to process. Stable position, value capture constrained by the industry pricing cycle. Regulatory trend (headwind): collection conduct, small-amount/responsible lending are tightening in developed markets — a long-term cost/constraint (structural headwind). Technology: data/AI can improve PDL pricing + collection efficiency (a positive for efficiency), but also lower entry barriers (potentially intensifying competition). Li Lu question: a 'discipline-driven distressed-asset processor cycling through consumer credit' — in 20 years consumer credit + defaulted debt still exist, and CCP, if it keeps its discipline culture, likely stays the ANZ leader with a US/UK footprint. It won't change civilization, growth is cycle/regulation-constrained, but crosses cycles on management discipline — sowing at troughs, reaping later. A plain financial niche with a regulatory headwind, value capture dependent on discipline — a 'cyclical financial steered by an excellent jockey,' not a structural growth story.

7. Valuation & Scenarios — Buffett + Duan

PE(TTM) 9.8x / forward 8.5x / 5.1% yield / down ~63% from the 2021 peak. Reverse-read: 8.5x forward + 5.1% yield + 16% earnings recovery prices 'cycle top / regulatory risk / FY24 trust not fully restored' — almost no premium for US/UK growth, disciplined management or continued recovery. If growth delivers + discipline holds, deeply undervalued; if PDL competition compresses returns / regulation tightens / US stumbles again, the discount is fair. Vs history: CCP traded 13-18x in good times, 8-10x in troughs; now at a trough multiple. Vs peers: global debt-buyers (Encore/PRA/Intrum) trade single-digit-to-low-teens at cycle bottoms; CCP at 8.5x forward is low, relatively cheap given disciplined management + recovery.

Three scenarios (base EPS A$1.55, tool-verified):

3-year: Bull 12% growth / 13x → A$28.3 (+106%, 30%); Base 6% / 10.5x → A$19.4 (+41%, 45%); Bear −4% / 8x → A$11.0 (−20%, 25%). Prob-weighted ≈ A$20.0 (+45%). 5-year: Bull → A$35.5 (+158%, 33%); Base → A$21.8 (+58%, 42%); Bear → A$10.1 (−27%, 25%). Prob-weighted ≈ A$23.4 (+70%). (3-year base A$19.4 ≈ analyst consensus A$18.62.)

Adding the ~5.1% dividend: prob-weighted total return ~18%/yr (3yr), ~16%/yr (5yr) — among the highest of the group. Strongly positive risk/reward — cheap (8.5x) + excellent management discipline + earnings recovery + US/UK growth options. The keys: (1) US/UK growth + lending volume; (2) PDL pricing discipline + recovery + re-rating toward historical 11-13x. Downside = cycle + execution + regulation (bear −20 to −27%); no NTA floor (weaker than the REITs/HVN), but the cheap multiple + 5.1% yield + recovery cushion partly. Key-person risk: the core alpha is Beregi's discipline — succession is a variable to track.

Duan question ('hold 5 years?'): inclined yes, especially for the management — Beregi's capital discipline is the scarcest alpha in this cyclical business, worth entrusting; 8.5x cheap + 5.1% yield + earnings recovery + down 63% from peak; multiple growth curves (US/UK/lending); counter-cyclical (buys cheap debt in downturns, sowing). Reservations: cyclical, capital-intensive, regulation-sensitive, US-execution bumps, key-person risk. Duan: what I'm really buying is Beregi and his discipline — restraint while others are greedy is priceless in a cyclical industry. Add cheap + recovery + growth options, and I'll hold a medium position. But it's a cyclical with regulatory and key-person risk — I won't bet the house like a Moutai.

8. Decision Memo

Decision: No position: medium position — 'excellent disciplined management + cheap (8.5x) + earnings recovery + US/UK growth options.' At A$13.76 (63% below peak, 8.5x forward, 5.1% yield) strongly positive (prob-weighted 3yr +45%/5yr +70%, bear −20 to −27%). It's a cyclical financial — avoid chasing at a PDL-boom top (when rivals scramble for debt); ideal add A$10-12 (near 52-week low, yield >5.5%); track PDL pricing discipline, US/UK execution, consumer-lending losses, regulation, Beregi succession; downside has no NTA floor — size moderately. Hold: hold — great management + cheap + recovery + growth; base 3yr +41%/5yr +58%; core is trusting Beregi's discipline. Sell signals: industry PDL pricing stays irrational, CCP forced to overpay / returns keep compressing; US/UK major stumble/writedown again; major regulatory tightening; consumer-lending losses out of control; Beregi departs and successor's discipline in doubt (core alpha impaired). Add signals: industry trough — rivals exit, CCP buys PDLs cheaply (counter-cyclical sowing); US/UK growth clearly delivers, EPS toward A$1.8-2.2+; earnings recovery continues; price A$10-12 (thicker margin of safety); consumer-lending volume record with controlled losses.

One-line conclusion: an 'over-sold (63% below peak), cheap (8.5x forward), earnings-recovering, cyclical specialist financial steered by a rare disciplined manager (Beregi ~18 years), with US/UK/consumer-lending growth options.' Not a REIT's 'NTA floor,' not SHL's 'steady utility' — a 'excellent management discipline (biggest moat) + cheap + recovery + growth options vs cyclical + capital-intensive + regulation-sensitive + US-execution bumps + key-person risk + no asset floor' value/recovery bet. Prob-weighted 3-year ≈ A$20.0 (+45%, ~18%/yr incl dividend — among the highest of the group); 5-year ≈ A$23.4 (+70%, ~16%/yr); bull (US/UK delivers + disciplined buying + re-rate) 5-year A$35.5 (+158%); bear (PDL competition/US stumble/regulation) A$10.1-11.0 (−20 to −27%). Strongly positive risk/reward, but high variance, no asset floor. For investors who prize management quality, can accept cyclicality, and want to back 'excellent discipline + cheap + recovery growth' — the core belief is 'trust Beregi's capital discipline'; the core risks are cycle/regulation/key-person succession.

Four-Master Commentary

Buffett: "In a financial, what I prize most is management discipline and integrity — Beregi sitting on his hands while rivals scramble for debt, then striking after they blow up, is exactly the anti-human restraint I admire. 8.5x, a 5% yield, earnings recovering, and a fair price. My worries are regulation and the lack of a net-asset floor — but a management I trust plus a cheap price is worth a bet."

Munger: "Reverse it — how do I lose? The industry scrambles for debt and crushes returns, or the US stumbles again, or regulators swing an axe. All real. But in a capital-cycle industry, the only reliable moat is discipline, and CCP has it. What I fear most is a successor chasing overpriced debt in a boom after Beregi retires — that would ruin everything. Watch the succession; otherwise the odds are good."

Duan Yongping: "What I'm buying is really Beregi. Buying bad debt and lending sub-prime isn't my favorite — cyclical, regulators watching. But a manager who's stayed disciplined for 18 years, striking counter-cyclically, is priceless in this industry. Add cheap, recovery, and growth options — I'll hold a medium position. But it's a cyclical with key-person risk; I won't bet the house."

Li Lu: "Consumer credit and defaulted debt will still exist in 20 years, and CCP, crossing cycles on discipline and sowing at troughs, is likely still the ANZ leader with a US/UK footprint. It won't change civilization, and it carries a regulatory headwind — but an excellent jockey earning excess returns in a plain industry is itself scarce. A good rider on an ordinary cyclical horse — bet on the rider, but don't forget the horse's temperament (cycle and regulation)."